ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 215

Relationship Between Structural Joint Damage and Urate Deposition In Gout: A Site-By-Site Analysis Using Plain Radiography and Dual Energy Computed Tomography

Nicola Dalbeth1, Opetaia Aati2, Ramanamma Kalluru3, Anne Horne2, Anthony Doyle4 and Fiona M. McQueen5, 1Medicine, University of Auckland, Auckland, New Zealand, 2Department of Medicine, University of Auckland, Auckland, New Zealand, 3Department of Rheumatology, Auckland District Health Board, Auckland, New Zealand, 4University of Auckland, Auckland, New Zealand, 5Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Bone, Computed tomography (CT), gout and radiography

  • Tweet
  • Email
  • Print
Session Information

Title: Imaging of Rheumatic Diseases I: Imaging in Gout, Pediatric, Soft and Connective Tissue Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: Structural joint damage, including erosion, joint space narrowing (JSN) and new bone formation (NBF), is frequently observed in patients with tophaceous gout.  Although imaging studies have implicated tophi in the development of these changes, the relationship between monosodium urate (MSU) crystals and structural joint damage has not been examined.  The aim of this work was to examine the relationship between joint damage and MSU crystal deposition in patients with tophaceous gout. 

Methods: Plain radiographs and dual energy computed tomography (DECT) scans of the feet were prospectively obtained from 92 patients with tophaceous gout. Two readers analysed the 10 metatarsophalangeal joints (MTPJs) for the presence of MSU crystals using DECT (920 total joints analysed, inter-reader agreement 94.2% and kappa 0.82).  For the purposes of analysis, DECT MSU crystal deposition was considered present if recorded by both readers.  A further reader, who was blinded to the DECT results, scored the same joints on plain radiography for Sharp-van der Heijde erosion score (0-10), JSN score (0-4) and presence of NBF features (spur, sclerosis and osteophyte).

Results: DECT MSU crystal deposition was more frequently observed in joints with erosion (odds ratio (OR) 11.2), JSN (OR 5.1), spur (OR 13.4), osteophyte (OR 5.3) and sclerosis (OR 9.1), p <0.0001 for all.  For those joints with any erosion, erosion scores were higher in joints with DECT urate deposition compared with those without MSU crystals (mean (SD) erosion scores 5.2 (2.7) and 3.3 (2.11) respectively, p<0.0001). A strong linear relationship was observed in the frequency of joints affected by MSU crystals with increasing radiographic erosion score (p<0.0001).  In contrast, for those joints with any narrowing, JSN scores were no different in those with and without DECT urate deposition (p=0.75).  DECT MSU crystal deposition and all features of joint damage were most frequently observed at the 1st MTPJ (Figure).  There was a very high correlation between the number of joints at each site affected by MSU crystal deposition and all features of radiographic joint damage (r>0.88 for all, p<0.05 for all).

Conclusion: MSU crystals are frequently present in joints affected by radiographic damage in patients with gout.  These findings support the concept that MSU crystals directly interact with articular tissues to influence the development of structural joint damage in this disease.

Figure: Examples of plain radiographs (upper panel) and corresponding axial DECT images (lower panel) of eroded 1st MTPJs from three separate participants.  MSU crystals are shown as red on DECT images.

P:GoutNBF DECT analysisFigure XR and DECT.jpg


Disclosure:

N. Dalbeth,
None;

O. Aati,
None;

R. Kalluru,
None;

A. Horne,
None;

A. Doyle,
None;

F. M. McQueen,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/relationship-between-structural-joint-damage-and-urate-deposition-in-gout-a-site-by-site-analysis-using-plain-radiography-and-dual-energy-computed-tomography/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology